01.12.2012 Views

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

MAGICAL MEDICINE: HOW TO MAKE AN ILLNESS ... - Invest in ME

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

410<br />

There was no acknowledgement from either the MRC BSU or from Dr Johnson; however just after the letters<br />

had been sent to the MRC, it was observed that much of Dr Johnson’s Report had been removed from the<br />

MRC BSU website, <strong>in</strong>dicat<strong>in</strong>g that this was a matter of some importance to the MRC.<br />

In statistical terms, the deletions from Dr Johnson’s Report amounted to a substantial 42% of the entire<br />

Report.<br />

Almost a full month later, a letter dated 10 th October 2006 was received from Dr Anthony Peatfield, which<br />

said: “You refer to some text that was recently published on the website of the MRC Biostatistics Unit. The comments<br />

to which you refer were drawn from a progress report produced by an <strong>in</strong>dividual member of staff. The comments have<br />

now been removed from the website. I would like to take this opportunity to apologise, on behalf of the MRC, for<br />

any offence these comments may have caused either to yourself or any other <strong>in</strong>dividual. While the comments were ill‐<br />

judged, it was not the <strong>in</strong>tention of the <strong>in</strong>dividual who wrote them, nor the Unit <strong>in</strong> publish<strong>in</strong>g them, to cause offence”.<br />

Curiously, Dr Peatfield further advised that should anyone else contact the MRC about this same matter:<br />

“we shall reply to any further requests such as your own as <strong>in</strong>dicated <strong>in</strong> the third paragraph, above”, mean<strong>in</strong>g that he<br />

would simply offer an ‘apology’ regardless of what <strong>in</strong>formation or clarification was be<strong>in</strong>g requested.<br />

Peatfield’s reply implied that those damag<strong>in</strong>g comments were not made by anyone of significance at the<br />

MRC, when <strong>in</strong> fact they had been written by the Deputy Director of the MRC Biostatistics Unit who was<br />

<strong>in</strong>tr<strong>in</strong>sically <strong>in</strong>volved with the actual design of the PACE trial, namely Dr Tony Johnson.<br />

Out of ten Reports that constituted the Qu<strong>in</strong>quennial Review, the only <strong>in</strong>dividual report from which<br />

sections were removed, <strong>in</strong>clud<strong>in</strong>g the Abstract, is that of Dr Johnson.<br />

The Abstract could not, however, be removed from the Review Index, where all ten Abstracts by different<br />

<strong>in</strong>dividuals are located, with l<strong>in</strong>ks to their full documents. In the case of Dr Johnson’s “re‐edited”<br />

document, the l<strong>in</strong>k to the Abstract no longer works, but the l<strong>in</strong>k works for all the other Abstracts. Was this a<br />

ploy by the MRC to conceal Johnson’s Abstract, with its references to his close association with the Institute<br />

of Psychiatry?<br />

Amongst large amounts of text removed from Dr Johnson’s Report were details of exactly how <strong>in</strong>fluential<br />

Dr Johnson has been with<strong>in</strong> the MRC and with the Institute of Psychiatry, particularly <strong>in</strong> terms of secur<strong>in</strong>g<br />

MRC fund<strong>in</strong>g, along with other details of his close connections to key <strong>in</strong>dividuals <strong>in</strong>volved <strong>in</strong> the PACE<br />

trial. The follow<strong>in</strong>g extracts are taken from the Abstract, which was removed <strong>in</strong> its entirety from the body of<br />

Dr Johnson’s Report:<br />

“Abstract<br />

“I have <strong>in</strong>itiated, developed, and collaborated <strong>in</strong> both cl<strong>in</strong>ical trials and epidemiological studies <strong>in</strong> four challeng<strong>in</strong>g<br />

medical specialties work<strong>in</strong>g with a large number of collaborators geographically dispersed throughout UK, Europe, and<br />

beyond. These have resulted <strong>in</strong> major advances <strong>in</strong> the understand<strong>in</strong>g of the efficacy of cognitive therapy.<br />

“Over many years my programme has contributed to the successful completion of the three largest cl<strong>in</strong>ical trials, all of<br />

major <strong>in</strong>ternational importance. My programme will be exploited <strong>in</strong> the future <strong>in</strong> further collaborations with the<br />

pharmaceutical <strong>in</strong>dustry.<br />

“I have enabled a successful collaboration l<strong>in</strong>k<strong>in</strong>g the research programmes of this Unit with the MRC Cl<strong>in</strong>ical Trials<br />

Unit (MRC CTU) <strong>in</strong> London, that has resulted <strong>in</strong> the establishment of a new Cl<strong>in</strong>ical Trials Unit dedicated to mental<br />

health and neurological sciences at the Institute of Psychiatry <strong>in</strong> London. The l<strong>in</strong>kage has enabled my expertise <strong>in</strong><br />

cl<strong>in</strong>ical trials to be extended to chronic fatigue syndrome and the sett<strong>in</strong>g‐up of a major MRC study to evaluate the<br />

efficacy of four different <strong>in</strong>terventions.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!